← SynDRA
RALFINAMIDE
SynDRA canonical compound SYN0033227 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | CACNA1B |
|---|
| Mechanism of action | sodium channel blocker |
|---|
All known targets
- CACNA1B
- MAOB
- SCN10A
- SCN11A
- SCN1A
- SCN2A
- SCN3A
- SCN4A
- SCN5A
- SCN7A
- SCN8A
- SCN9A
Mechanisms of action (all sources)
- CACNA1B BLOCKER
- Voltage-gated N-type calcium channel alpha-1B subunit blocker
- MAOB INHIBITOR
- Monoamine oxidase B inhibitor
- SCN1A BLOCKER
- Sodium channel alpha subunit blocker
- SCN5A BLOCKER
- SCN4A BLOCKER
- SCN7A BLOCKER
- SCN2A BLOCKER
- SCN9A BLOCKER
- SCN3A BLOCKER
Cross-references
Synonyms
- Priralfinamide
- Priralfinamida
- Nw-1029
- FCE-26742A
- NW1029
- PNU-0154339E
- Ralfinamida
- Ralfinamide [INN]
- NW-1029
- Ralfinamida [INN-Spanish]
- (2S)-2-(4-(2-Fluorobenzyloxy)benzylamino)propanamide
- (2S)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide
- priralfinamida
- 3LPF0S0GVV
- priralfinamidum
- RefChem:176026
- DTXCID3080897
- (S)-2-((4-((2-Fluorobenzyl)oxy)benzyl)amino)propanamide
- Priralfinamide [INN]
- MFCD08272558
- UNII-3LPF0S0GVV
- (S)-2-[[4-[(2-Fluorobenzyl)oxy]benzyl]amino]propanamide
- Safinamide Impurity 32
- (S)-2-[4-(2-fluorobenzyloxy)benzylamino]propanamide
- SCHEMBL67328
- orb1299896
- SCHEMBL29379049
- WLZ5166
- BHJIBOFHEFDSAU-LBPRGKRZSA-N
- BDBM161094
- Safinamide Impurity O; Ralfinamide
- ARD193673
- EX-A14967
- AKOS016006629
- NCGC00370789-01
- DA-67107
- DS-18607
- SY118855
- HY-101437
Look up RALFINAMIDE in the interactive SynDRA portal →